KRRO Live signals | Maximize Profits with Getagraph.com

SELL 128129 min ago

@ $67.74

Issued: 5 Feb 2024 @ 15:50

Return: -14.02%

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases...

Stats
Today's Volume	15 337.00
Average Volume	34 645.00
Market Cap	467.28M
EPS	$-25.65 ( 2024-03-29 )
Next earnings date	( $-2.36 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.300 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	New Enterprise Associates 17, L.p.	Buy	17 857	Common Stock
2024-04-22	Baskett Forest	Buy	17 857	Common Stock
2024-04-22	Behbahani Ali	Buy	17 857	Common Stock
2024-04-22	Florence Anthony A. Jr.	Buy	17 857	Common Stock
2024-04-22	Walker Paul Edward	Buy	17 857	Common Stock

INSIDER POWER
100.00
Last 13 transactions
Buy: 214 284 \| Sell: 0

Volume Correlation

Long: 0.13 (neutral)

Short: 0.08 (neutral)

Signal:(48.632) Neutral

Korro Bio, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Korro Bio, Inc. Correlation - Currency/Commodity

0.00
( neutral )

0.21
( neutral )

0.26
( neutral )

-0.17
( neutral )

0.34
( neutral )

-0.24
( neutral )

Korro Bio, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-3.63M (0.00 %)
EPS:	$-53.09

FY	2023
Revenue:	$0
Gross Profit:	$-3.63M (0.00 %)
EPS:	$-53.09

Financial Reports:

No articles found.

Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.